US OptionsDetailed Quotes
ANIX240816C2500
- 0.70
- 0.000.00%
15min DelayTrading Jul 15 15:15 ET
0.00High0.00Low
0.00Open0.70Pre Close0 Volume2 Open Interest2.50Strike Price0.00Turnover169.04%IV11.11%PremiumAug 16, 2024Expiry Date0.38Intrinsic Value100Multiplier24DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type0.7142Delta0.2670Gamma4.11Leverage Ratio-0.0091Theta0.0009Rho2.94Eff Leverage0.0026Vega
Anixa Biosciences Stock Discussion
Sign in to post a comment
$Anixa Biosciences(ANIX.US$ sad no movement
3
$Anixa Biosciences(ANIX.US$ EXCLUSIVE: Anixa Biosciences Tells Benzinga Co. Announces FDA Approval Of Individual Patient IND For Its Ovarian Cancer CAR-T Therapy
4
8
$Anixa Biosciences(ANIX.US$ Reuters· 7 mins ago
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
1
$Anixa Biosciences(ANIX.US$
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Anixa Biosciences (NASDAQ: ANIX) announced that its collaborator, Cleveland Clinic, has received a 'Decision to Grant' notice from the Japan Patent Office for a patent application on breast cancer vaccine technology.
This extends the patent protection to Japan, in addition to existing U.S. and European patents.
Anixa is the exclusive worldwide licensee of this technology.
The vacci...
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Anixa Biosciences (NASDAQ: ANIX) announced that its collaborator, Cleveland Clinic, has received a 'Decision to Grant' notice from the Japan Patent Office for a patent application on breast cancer vaccine technology.
This extends the patent protection to Japan, in addition to existing U.S. and European patents.
Anixa is the exclusive worldwide licensee of this technology.
The vacci...
Anixa Biosciences: Current Developments and Future Prospects.
On Monday, H.C. Wainwright & Co. adjusted its outlook on Anixa Biosciences (NASDAQ: ANIX) shares, reducing the 12-month price target to $7.00 from the previous $12.00 while maintaining a Buy rating. This adjustment is based on a recent financial report and a new partnership focused on cancer vaccine development. $Anixa Biosciences(ANIX.US$
https://stockregion.app/p/prominent-investment-bank-maintains
On Monday, H.C. Wainwright & Co. adjusted its outlook on Anixa Biosciences (NASDAQ: ANIX) shares, reducing the 12-month price target to $7.00 from the previous $12.00 while maintaining a Buy rating. This adjustment is based on a recent financial report and a new partnership focused on cancer vaccine development. $Anixa Biosciences(ANIX.US$
https://stockregion.app/p/prominent-investment-bank-maintains
$Anixa Biosciences(ANIX.US$
NEWS
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences has commenced treatment of the fifth patient in its Phase 1 clinical trial for CAR-T therapy targeting ovarian cancer. This trial, conducted in partnership with Moffitt Cancer Center, enrolls female patients with recurrent ovarian cancer unresponsive to at least two prior therapies. The trial aims to identify the maximum tolerated dose of T-cells targe...
NEWS
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences has commenced treatment of the fifth patient in its Phase 1 clinical trial for CAR-T therapy targeting ovarian cancer. This trial, conducted in partnership with Moffitt Cancer Center, enrolls female patients with recurrent ovarian cancer unresponsive to at least two prior therapies. The trial aims to identify the maximum tolerated dose of T-cells targe...
$Anixa Biosciences(ANIX.US$
NEWS
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
NEWS
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
No comment yet
RumRation : Yeah other news gained more attention. This was a great announcement though. Very promising results with minimal dose.
RumRation : I think it will pick up steam later today as other hot stocks cool down
Don’tTalkAboutBrunoOP RumRation: Hopefully